Applied DNA Sciences
Founded Year
1983Stage
Other Investors | IPOMarket Cap
0.01BStock Price
0.85Revenue
$0000About Applied DNA Sciences
Applied DNA Sciences is a company that focuses on molecular-based security and operates in the supply chain authentication and diagnostics industries. The company offers services such as supply chain authentication across various industries and large-scale linear DNA production for diagnostics and vaccines. It primarily serves sectors such as textiles, dietary supplements, and pharmaceuticals. Applied DNA Sciences was formerly known as Prohealth Medical Technologies. It was founded in 1983 and is based in Stony Brook, New York.
Loading...
Loading...
Research containing Applied DNA Sciences
Get data-driven expert analysis from the CB Insights Intelligence Unit.
CB Insights Intelligence Analysts have mentioned Applied DNA Sciences in 1 CB Insights research brief, most recently on Feb 2, 2022.
Expert Collections containing Applied DNA Sciences
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Applied DNA Sciences is included in 1 Expert Collection, including Supply Chain & Logistics Tech.
Supply Chain & Logistics Tech
3,811 items
Companies offering technology-driven solutions that serve the supply chain & logistics space (e.g. shipping, inventory mgmt, last mile, trucking).
Applied DNA Sciences Patents
Applied DNA Sciences has filed 16 patents.
The 3 most popular patent topics include:
- abandoned drugs
- amines
- biotechnology
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
12/17/2019 | 1/4/2022 | Molecular biology, Cellulose, DNA sequencing, Papermaking, Biotechnology | Grant |
Application Date | 12/17/2019 |
|---|---|
Grant Date | 1/4/2022 |
Title | |
Related Topics | Molecular biology, Cellulose, DNA sequencing, Papermaking, Biotechnology |
Status | Grant |
Latest Applied DNA Sciences News
Sep 7, 2023
Beverly Wolgast will lead implementation of cGMP-quality LineaDNA Capability for IVT mRNA Production. 09.07.23 Applied DNA Sciences, a company involved in PCR-based DNA technologies, appointed Beverly Wolgast, executive director of Quality and cGMP Programs. Wolgast will oversee and manage Applied DNA's quality assurance and control and regulatory compliance spanning the company's three business segments, including implementing an ISO 13485-based quality management system for the scalable cGMP manufacture of LineaDNA. Wolgast brings over 30 years of pharmaceutical and biotech experience in commercial and clinical-stage companies, with a proven track record of quality and regulatory compliance management and expertise in commercial biologics manufacturing operations. Most recently, she was Director of CleanCap GMP Manufacturing at TriLink BioTechnologies, a contract development and manufacturing organization (CDMO) and division of Maravai LifeSciences, where she also provided leadership for TriLink's manufacture of the mRNA-based BioNTech/Pfizer COVID-19 vaccine. Wolgast has a record of mobilizing technical resources and achieving efficient compliance solutions to address business needs. Her expertise includes industry regulatory compliance, program management, operational readiness, process engineering, lab operations, automation engineering, and technical validation. "Beverly's wealth of experience and deep knowledge of nucleic acid-based therapy manufacturing will be instrumental in implementing scalable, highly efficient, and consistent quality and manufacturing processes necessary to support Linea IVT platform customers from early-stage drug discovery through late-phase clinical trials,” said James A. Hayward, president, and CEO of Applied DNA. “A successful operational leader in the CDMO industry, her appointment also signals to CDMOs that are likely customers of our platform that we are moving with intent to help them meet the industry's need for better mRNA. It is an important time for Applied DNA as we advance our LineaDNA commercial activities, and Beverly's appointment supports our vision for growth and value creation through our biopharma approach."
Applied DNA Sciences Frequently Asked Questions (FAQ)
When was Applied DNA Sciences founded?
Applied DNA Sciences was founded in 1983.
Where is Applied DNA Sciences's headquarters?
Applied DNA Sciences's headquarters is located at 50 Health Sciences Drive, Stony Brook.
What is Applied DNA Sciences's latest funding round?
Applied DNA Sciences's latest funding round is Other Investors.
Who are the investors of Applied DNA Sciences?
Investors of Applied DNA Sciences include Long Island High Technology Incubator.
Who are Applied DNA Sciences's competitors?
Competitors of Applied DNA Sciences include InfraTrac.
Loading...
Compare Applied DNA Sciences to Competitors
TruTag Technologies is a technology solution provider specializing in the field of product authentication across various industries such as pharmaceuticals, food, consumer products, and industrial & electronic parts. The company offers a unique technology that uses microscopic, edible barcodes, known as TruTags®, to tag, track, and trace various products, enabling real-time product authentication and quality assurance. These barcodes can be decoded by consumer-friendly mobile apps, providing a high level of supply chain transparency and security. It was founded in 2011 and is based in Emeryville, California.
InfraTrac chemically tags products and packaging so they can be quickly and easily authenticated in the field, without disclosing the secrets of the coding scheme. This allows brand owners to protect their products against counterfeiting. InfraTrac's principal competition comes from physical tags (RFID and EPC) and special inks, and tends to be more expensive or less secure... or both.
GeBe Cert provides a microchip and blockchain platform to protect users' brands, stop counterfeits and collect data. It utilizes encrypted microchips that can be incorporated with any physically manufactured product and then paired with the digital counterpart on the blockchain. The company was founded in 2018 and is based in Florham Park, New Jersey.
Linksmart DNA is a company that focuses on providing 'Non Clonable Identity of Things', operating in the technology and supply chain sectors. The company offers a range of services including non-clonable labels and prints, reusable packaging, and credible loyalty solutions, all aimed at securing supply chains at both the physical and digital layers. These services are primarily targeted towards industries that require secure and traceable supply chains. It is based in Bengaluru, India.
KORE Technologies is an information technology (IT) company. It specializes in creating and managing blockchain certificates for people and products (NFTs), enabling true digital assets and identities. The company enables companies and authorities to successfully realize the vision of counterfeit protection and automation. It was founded in 2018 and is based in Zug, Switzerland.
Stealth Mark Holdings (SMI) is a global product authentication solutions provider that offers advanced product security technologies available within the security and supply chain management vertical sectors. SMI provides customers true brand protection from counterfeiting and diversion while maintaining the integrity of product authentication. Stealth Mark solutions are based upon encrypted microparticle technology, state-of-the-art printing technologies, and a reader that can be used with iPhone and other smartphones. The reader working in conjunction with the StealthFire Software authenticates the Microparticle Mark and captures the unique ID, GPS validated location, and QR code.
Loading...